Key Data on Advanced NSCLC From ASCO 2023 Key Data on Advanced NSCLC From ASCO 2023

Data from KEYNOTE-789, plus results on the EGFR exon 20 inhibitor sunvozertinib and a promising sotorasib combination for KRAS G12C-mutant disease, are highlights in advanced NSCLC from ASCO 2023.Medscape
Source: Medscape Today Headlines - Category: Consumer Health News Tags: None ReCAP Source Type: news